ACTRN12605000425695进行中（未招募）1 期
VMCL Melanoma Vaccine Treatment Phase II Study for Therapy of Patients with Advanced Stage IV Melanoma
Royal Adelaide Hospital/University of Adelaide0 个研究点目标入组 50 人开始时间: 2005年9月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Stage IV advanced melanoma with soft tissue/organ metastases; Absence of Brain Metastases; Absence of ocular melanoma associated retinopathy /iritis; Willingness to attend all scheduled clinical visits, tests and blood sampling.
排除标准
- •Solitary bone metastases; Large volume metastatic disease; Poor performance status; Pregnancy; Other malignancy.
研究者
相似试验
已完成
2 期
Vaccine Plus Interleukin-2 in Treating Patients With Advanced MelanomaRecurrent MelanomaStage IV MelanomaNCT00005949National Cancer Institute (NCI)50
已完成
1 期
Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma CellsMelanomaNCT00515983José Mordoh, M.D., Ph.D.16
已完成
2 期
Phase II study of pre-emptive therapy against CMV-associated disesase by valganciclovir after allogeneic hematopoietic stem cell transplantatioPatients with CMV reactivation after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000000953Dept of 1st Intern Med, Kyushu Univ Hospital10
已完成
1 期
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma PatientsMelanomaNCT00559026Istituto Superiore di Sanità10
已完成
2 期
Clinical Study of Previously Untreated Patients With Malignant MelanomaMalignant MelanomaNeoplasm MetastasisNCT00232726Clavis Pharma42